
Mainboard IPO
Paras Healthcare IPO
Prices in INR · Times in IST
GMP updated: 28 Oct 2026, 08:24 AM IST
- Price band
- ₹660 – ₹693
- Application estimate
- ₹14,5531 lot(s) · 21 sh
- GMP · unofficial
- ₹13 (+1.88%)
- Est. listing price
- ₹706Issue price + GMP
- Issue size
- ₹1,450 Cr
- Total subscription
- 2.23×
GMP trend & intraday history
Hover or tap on the chart to inspect a reading. Dates use calendar spacing; large gaps are not connected.
- High in this view
- ₹96 (₹2,016)
- Low in this view
- ₹9 (₹189)
- Reference issue price
- ₹693
- Readings in this view
- 15
- Subject to sauda
- 300 / 4200
Issue at a glance
IPO timetable & schedule
Subscription by investor category
Source updated: 28 Oct 2026, 06:30 PM IST
Overall Demand: 2.23×Mainboard figures are consolidated. NSE and BSE demand is not added together. Rupee demand is calculated from bid shares and the cap price; it is not an exchange-published amount. Application source: boa.
QIB funding cost illustration
Arithmetic for a fully funded institutional bid over 7 days; not a recommendation or a retail return estimate.
- Days
- 7
- Interest Rate
- Not published
- Cost Per Share
- 2141.37
Day-wise subscription history
One snapshot near each bidding day’s close. This is not a continuous intraday series.
Plan your application
Estimate uses the published lot size and upper price band. Confirm your category and the offer terms before applying.
One lot: ₹14,553 · Allocation is not guaranteed. Broker cut-off times may differ.
Source-published application tiers
Before you place an IPO application
- Read the issue. Check the offer document, business risks, price band and your application category.
- Apply through your broker or bank. Use your existing broker’s IPO section or your bank’s ASBA facility. This page does not submit a bid.
- Check the payment step. If using UPI, confirm the mandate in your UPI app and check that the funds are blocked. A saved bid alone is not confirmation.
- Track what happens next. Keep your application number. Use the registrar’s official page for allotment and the published timeline for refunds, demat credit and listing.
GMP return scenario
What could this amount look like?
GMP-based scenario · Not a forecast
Assumes all requested shares are allotted and listing equals issue price + GMP. Actual allotment, listing price, fees and taxes can change the result.
Your IPO progress
Keep your own record of this IPO. Statuses are entered by you, not verified with a broker or registrar. Saved on this browser for your signed-in account; not synced across devices.
IPO reservation & shares offered
Shares offered by category
Category-wise allocation percentages follow SEBI ICDR norms as stated in the offer document.
Promoter holding & ownership
Dr. Dharminder Kumar Nagar
Dr. Dharminder Kumar Nagar holds 7,35,19,238 shares or 72.80% of the pre-offer paid up equity share capital, and the two promoter group members, Gurdeep Kaur Nagar and Ranya Nagar, hold one share each. Commelina Ltd holds 16.44% and the 360 ONE funds together hold just over 7%.
Anchor investors & allocations
- Anchor entities
- 39
- Total allocation (₹ crore)
- 652.5
- Mutual fund allottees
- 24
- Official allocation document
- Anchor document: not published
Investor allocations
By fund house
Financials & valuation
Figures in Rs. Crore · Changes compare matching annual period-end dates only.
- Revenue from Operations
- —Latest: 30 Jun 2026Prior (31 Mar 2026): 1,605.95 · YoY unavailable
- Profit After Tax
- 49.68Latest: 30 Jun 2026Prior (31 Mar 2026): 43.83 · YoY unavailable
- EBITDA
- 113.48Latest: 30 Jun 2026Prior (31 Mar 2026): 335.58 · YoY unavailable
- Total Borrowing
- 1,429.49Latest: 30 Jun 2026Prior (31 Mar 2026): 1,393.86 · YoY unavailable
Rs. Crore
Key valuation & financial KPIs
- P/E Ratio
- 37.72
- EPS (₹)
- 18.37
- RoE
- 11.83%
- RoCE
- 4.23%
- RoNW
- 11.83%
- PAT Margin
- 10.38%
- EBITDA Margin
- 23.70%
- Debt / Equity
- 3.21
- NAV (₹)
- 44.06
What does the company do?
Paras Healthcare Limited is a clinical specialty-led hospital platform that provides tertiary and quaternary healthcare through a network of eight hospitals with an aggregate capacity of 2,211 beds as on 31 March 2026. It operates under the Paras Health brand and is based at Paras Twin Towers, Golf Course Road, Sector 54, Gurugram, Haryana. Its critical care infrastructure includes organ and condition-specific ICUs, with 559 ICU beds as on 31 March 2026, up from 425 beds in FY2024. The hospitals employed 1,011 doctors and 1,665 nurses on the same date. The hospitals are spread over five states and one union territory. They are in Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand and Srinagar in Jammu and Kashmir. The Gurugram hospital has run for 20 years and the Patna hospital for 12 years, while the newest units at Srinagar and Kanpur have run for three years and two years. Of the eight, four are super-specialty tertiary care hospitals and four are multi-specialty tertiary care hospitals. Six of the eight run on leased premises, five through revenue share arrangements and long-term leases and one under a public private partnership. The business is reported as a single healthcare services segment in a single geography. Work is concentrated in what the company calls CONGOR specialties, meaning cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences. Together these gave 74.70% of FY2026 revenue from operations, led by oncology at 21.63%, neuro sciences at 13.03% and cardiac sciences at 12.78%. Hospitals outside Gurugram, which the company counts as tier 2 cities, gave 68.18% of FY2026 revenue against 62.35% in FY2024. Operating metrics improved in FY2026. Operational beds rose to 1,502 from 1,465, the bed occupancy rate rose to 61.75% from 50.78%, and occupied bed days rose to 3,38,321 from 2,68,927. In-patient volumes were 1,15,496 and out-patient volumes 7,78,707 in FY2026, against 81,047 and 5,69,139 in FY2024, and the hospitals performed 39,687 surgeries. Average revenue per occupied bed was Rs 47,397.82 per day in FY2026, with the Gurugram hospital at Rs 70,925.76 per day and the Darbhanga hospital at Rs 19,980.75 per day. Average length of stay was 2.93 days. Payments come from three sources. Government schemes and public sector undertakings accounted for 41.28% of FY2026 revenue, self pay patients 33.88% and insurance and third party administrators 24.84%. In FY2024 the same shares were 29.76%, 40.63% and 29.61%. The promoter is Dr. Dharminder Kumar Nagar, the Managing Director, who has been with the company since 2003 and has over 22 years of experience in healthcare. He holds an MBBS from the University of Mysore and a master of philosophy in hospital and health systems management from BITS Pilani.
More about the business
Paras Healthcare runs eight tertiary and quaternary care hospitals under the Paras Health brand, with 2,211 beds across five states and one union territory. Revenue from operations grew 24.10% to Rs 1,605.95 crore in FY2026 and the company reported a profit of Rs 43.83 crore after two years of losses.
Where will the money go?
Strengths & risks
Business strengths
- Revenue from operations grew 24.10% to Rs 1,605.95 crore in FY2026, after 14.62% growth in FY2025.
- The company turned profitable in FY2026 with a profit of Rs 43.83 crore, against a loss of Rs 57.98 crore in FY2025 and a loss of Rs 15.33 crore in FY2024.
- EBITDA grew 114.48% from Rs 156.46 crore in FY2025 to Rs 335.58 crore in FY2026.
- The bed occupancy rate rose to 61.75% in FY2026 from 50.78% in FY2025, with Gurugram at 83.85% and Patna at 73.16%.
- For the quarter ended 30 June 2026 the source lists return on equity of 11.83% and return on capital employed of 4.23%. These are on one quarter's profit and are not annualised.
- Volumes are growing across the network. In-patient volumes rose to 1,15,496 in FY2026 from 81,047 in FY2024 and out-patient volumes to 7,78,707 from 5,69,139, with 39,687 surgeries in FY2026.
- ICU capacity grew to 559 beds as on 31 March 2026 from 425 beds in FY2024, supporting the high-acuity work that gives 74.70% of revenue.
- Cash flow from operations was Rs 163.51 crore in FY2026 against Rs 86.19 crore in FY2025, so the operating profit is converting into cash.
Risks to understand
- The profit record is short. The company lost Rs 57.98 crore in FY2025 and Rs 15.33 crore in FY2024, and FY2026 is its first profitable year of the three shown, with a profit margin of only 2.69% of total income.
- Two subsidiaries, Paras Healthcare (Ranchi) and Plus Medicare Hospitals, together lost Rs 52.09 crore in FY2026, Rs 82.24 crore in FY2025 and Rs 87.27 crore in FY2024.
- Total borrowings rose to Rs 1,393.86 crore as on 31 March 2026 from Rs 923.92 crore in FY2024 against a net worth of Rs 394.94 crore, and the debt to equity ratio was 3.53 times.
- Attrition among doctors, nurses and support staff was 60.38% in FY2026, 66.74% in FY2025 and 65.27% in FY2024.
- Five of the eight hospitals are in North India and gave 66.07% of FY2026 revenue from operations, so one region drives most of the business.
- CONGOR specialties gave 74.70% of FY2026 revenue from operations, so demand for six clinical lines decides the top line.
- Government schemes and public sector undertakings now pay for 41.28% of revenue against 29.76% in FY2024, while self pay fell to 33.88% from 40.63%, and the company says its scheme empanelments have faced suspension and temporary restrictions in the past.
- Six of the eight hospitals run on leased premises, five under revenue share and long-term lease arrangements and one under a public private partnership, so renewal terms are outside the company's control.
- The offer for sale is Rs 950.00 crore of the Rs 1,450.00 crore offer, and only Rs 500.00 crore is fresh money for the company. The promoter is selling Rs 300.00 crore of shares and Commelina Ltd is selling Rs 650.00 crore, as per the estimated amounts shown at the source.
- Average revenue per occupied bed slipped to Rs 47,397.82 per day in FY2026 from Rs 48,088.57 in FY2025, with Srinagar falling to Rs 36,532.56 from Rs 62,401.30, so occupancy rather than pricing drove the growth.
Source-provided company information. Read the RHP for the complete risk factors; these points are not a recommendation.
Listing performance
Actual listing figures appear after listing. Current gain is source-adjusted for corporate actions. CMP is a source snapshot, not a streaming quote.
Official documents, registrar & contacts
Offer documents
MUFG Intime India Private Limited
Phone: 022-49186000
Email: parashealthcare.ipo@in.mpms.mufg.com
Allotment date: 26 Oct 2026
- •JM Financial Ltd.
- •Nuvama Wealth Management Ltd.
- •Bofa Securities India Limited
1st Floor, Tower B, Paras Twin Towers, Golf Course Road, Sector 54, Gurugram 122 002, Haryana, India
Phone: +91 124 430 2163
Email: cs@parashospitals.com
Continue your IPO research
Explore more IPO companies
Related by issue type, with active issues first. These are research links, not investment recommendations.